Addus HomeCare (NASDAQ:ADUS) Upgraded at StockNews.com

StockNews.com upgraded shares of Addus HomeCare (NASDAQ:ADUS) from a hold rating to a buy rating in a report issued on Wednesday.

Several other research analysts have also recently commented on the stock. Macquarie reaffirmed an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a report on Monday, November 4th. Oppenheimer raised their price objective on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. Stephens upped their target price on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. KeyCorp started coverage on Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target on the stock. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a research note on Thursday, November 14th. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Addus HomeCare currently has a consensus rating of “Moderate Buy” and an average target price of $131.63.

Addus HomeCare Trading Up 2.5 %

ADUS stock opened at $125.00 on Wednesday. Addus HomeCare has a 1-year low of $85.94 and a 1-year high of $136.12. The business’s 50 day simple moving average is $125.64 and its 200 day simple moving average is $124.37. The firm has a market capitalization of $2.27 billion, a PE ratio of 28.60, a PEG ratio of 2.11 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping the consensus estimate of $1.28 by $0.02. The business had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.03 EPS. As a group, sell-side analysts predict that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the company’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the transaction, the chief executive officer now owns 141,897 shares in the company, valued at $17,476,034.52. This represents a 8.10 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.60% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

Large investors have recently modified their holdings of the company. Ellsworth Advisors LLC bought a new position in Addus HomeCare in the 2nd quarter valued at about $598,000. SG Americas Securities LLC purchased a new stake in shares of Addus HomeCare in the second quarter worth approximately $842,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Addus HomeCare in the third quarter valued at approximately $1,622,000. Dimensional Fund Advisors LP boosted its position in shares of Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock valued at $82,930,000 after buying an additional 5,421 shares during the last quarter. Finally, Argent Capital Management LLC boosted its position in shares of Addus HomeCare by 51.5% during the second quarter. Argent Capital Management LLC now owns 37,310 shares of the company’s stock valued at $4,332,000 after buying an additional 12,685 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.